MG

Michael Gillespie

Investor | Planetary Health

Boston, Massachusetts

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $1,500,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Investment Director

    2022

    RA Capital’s Planetary Health team focuses on creating and funding companies that commercialize scalable, profitable solutions to reduce emissions, increase resource availability, and restore environmental quality, because solutions that heal the planet will yield both healthy people and healthy profits. Founded in 2004, RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies. RA Capital creates and funds innovative companies, from private seed rounds to public follow-on financings, allowing management teams to drive value creation from inception through commercialization and beyond. RA Capital's knowledge engine is guided by its TechAtlas internal research division, and Raven, RA Capital's healthcare incubator, offers entrepreneurs and innovators a collaborative and comprehensive platform to explore the novel and the re-imagined. RA Capital has more than 150 employees and over $10 billion in assets under management.

  • Senior Associate

    2022 - 2022

  • Associate

    2020 - 2022

  • Board Director

    2023

  • Board Director

    2022

2022 - 2024

  • Board Director

    2022 - 2024

2023 - 2024

  • Board Observer

    2023 - 2024

  • Board Observer

    2022 - 2023

2018 - 2020

  • Co Director of Texas Healthcare Challenge

    2018 - 2020

  • Product Development

    2017 - 2019

    Founded to explore and define the limits to human functional capacity in health and disease, with the objective of improving the quality of life for human beings of all ages.

  • Aerospace Medicine Clerk

    2019 - 2019

    The Aerospace Medicine Clerkship is a research-based program with formal lectures on space medicine topics and issues, as well as familiarization with the medical aspects of International Space Station operations, design, and function.

  • Technology Commercialization Intern

    2016 - 2018

    Manages UT Southwestern's technology transfer activities and facilitates the formation of biomedical companies based on UT Southwestern-developed technologies.